Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain phosphoserine binding	SCAF8 SCAF4	1.31e-04	5	73	2	GO:1990269
GeneOntologyBiologicalProcess	negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled	SCAF8 SCAF4	1.20e-05	2	72	2	GO:2000805
GeneOntologyBiologicalProcess	negative regulation of termination of RNA polymerase II transcription	SCAF8 SCAF4	1.20e-05	2	72	2	GO:0120191
GeneOntologyBiologicalProcess	negative regulation of termination of DNA-templated transcription	SCAF8 SCAF4	3.60e-05	3	72	2	GO:0060567
GeneOntologyBiologicalProcess	termination of RNA polymerase II transcription, poly(A)-coupled	SCAF8 SCAF4	3.60e-05	3	72	2	GO:0030846
GeneOntologyBiologicalProcess	positive regulation of cap-independent translational initiation	NCK1 YTHDF2	3.60e-05	3	72	2	GO:1903679
GeneOntologyBiologicalProcess	regulation of cap-independent translational initiation	NCK1 YTHDF2	3.60e-05	3	72	2	GO:1903677
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription, poly(A)-coupled	SCAF8 SCAF4	3.60e-05	3	72	2	GO:2000804
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription	SCAF8 SCAF4	7.18e-05	4	72	2	GO:1904594
GeneOntologyBiologicalProcess	negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	NCK1 DNAJC3	7.18e-05	4	72	2	GO:1903912
GeneOntologyBiologicalProcess	positive regulation of translation in response to endoplasmic reticulum stress	NCK1 DNAJC3	1.19e-04	5	72	2	GO:0036493
GeneOntologyBiologicalProcess	positive regulation of cytoplasmic translational initiation	NCK1 YTHDF2	1.19e-04	5	72	2	GO:1904690
GeneOntologyBiologicalProcess	cap-independent translational initiation	NCK1 YTHDF2	1.19e-04	5	72	2	GO:0002190
GeneOntologyBiologicalProcess	female gamete generation	SRC RXFP2 ASPM MASTL NCAPH YTHDF2	1.29e-04	223	72	6	GO:0007292
GeneOntologyBiologicalProcess	positive regulation of translational initiation	NCK1 DNAJC3 YTHDF2	1.40e-04	29	72	3	GO:0045948
GeneOntologyBiologicalProcess	regulation of termination of DNA-templated transcription	SCAF8 SCAF4	1.79e-04	6	72	2	GO:0031554
GeneOntologyBiologicalProcess	meiotic cell cycle	SMC3 CALR ASPM MASTL NUF2 NCAPH YTHDF2	2.18e-04	350	72	7	GO:0051321
GeneOntologyBiologicalProcess	eiF2alpha phosphorylation in response to endoplasmic reticulum stress	NCK1 DNAJC3	3.32e-04	8	72	2	GO:0036492
GeneOntologyBiologicalProcess	regulation of translation initiation in response to endoplasmic reticulum stress	NCK1 DNAJC3	3.32e-04	8	72	2	GO:0036491
GeneOntologyBiologicalProcess	positive regulation of translation in response to stress	NCK1 DNAJC3	3.32e-04	8	72	2	GO:0032056
GeneOntologyBiologicalProcess	regulation of cytoplasmic translational initiation	NCK1 YTHDF2	3.32e-04	8	72	2	GO:1904688
GeneOntologyBiologicalProcess	signal complex assembly	SRC NCK1	3.32e-04	8	72	2	GO:0007172
GeneOntologyBiologicalProcess	meiotic cell cycle process	CALR ASPM MASTL NUF2 NCAPH YTHDF2	3.47e-04	268	72	6	GO:1903046
GeneOntologyBiologicalProcess	nuclear division	SMC3 CALR BUB1 ASPM MASTL NUF2 SKA1 NCAPH	4.06e-04	512	72	8	GO:0000280
GeneOntologyCellularComponent	outer kinetochore	BUB1 NUF2 SKA1	7.84e-05	24	73	3	GO:0000940
GeneOntologyCellularComponent	nuclear matrix	SPTBN4 SMC3 SCAF8 MATR3 CLIC4	1.31e-04	140	73	5	GO:0016363
GeneOntologyCellularComponent	nuclear periphery	SPTBN4 SMC3 SCAF8 MATR3 CLIC4	3.31e-04	171	73	5	GO:0034399
MousePheno	axonal spheroids	DOCK3 DST MATR3	3.37e-05	17	53	3	MP:0010047
MousePheno	axonal dystrophy	DOCK3 SPTBN4 DST	7.53e-05	22	53	3	MP:0003225
MousePheno	small cerebellum	DOCK3 MATR3 PLXNB2 DNAH5 ZIC1	8.51e-05	119	53	5	MP:0000852
Domain	Calreticulin	CALR3 CALR	1.38e-05	2	70	2	IPR009169
Domain	Calret/calnex	CALR3 CALR	8.27e-05	4	70	2	IPR001580
Domain	CALRETICULIN_1	CALR3 CALR	8.27e-05	4	70	2	PS00803
Domain	CALRETICULIN_2	CALR3 CALR	8.27e-05	4	70	2	PS00804
Domain	Calret/calnex_CS	CALR3 CALR	8.27e-05	4	70	2	IPR018124
Domain	Calreticulin	CALR3 CALR	8.27e-05	4	70	2	PF00262
Domain	Calreticulin/calnexin_P_dom	CALR3 CALR	1.37e-04	5	70	2	IPR009033
Domain	RNA_pol_II-bd	SCAF8 SCAF4	2.87e-04	7	70	2	IPR006903
Domain	CTD_bind	SCAF8 SCAF4	2.87e-04	7	70	2	PF04818
Domain	RPR	SCAF8 SCAF4	3.82e-04	8	70	2	SM00582
Domain	CID	SCAF8 SCAF4	3.82e-04	8	70	2	PS51391
Domain	CID_dom	SCAF8 SCAF4	3.82e-04	8	70	2	IPR006569
Domain	CH	SPTBN4 DST ASPM	1.86e-03	65	70	3	SM00033
Domain	CH	SPTBN4 DST ASPM	2.31e-03	70	70	3	PF00307
Domain	-	SPTBN4 DST ASPM	2.40e-03	71	70	3	1.10.418.10
Domain	CH	SPTBN4 DST ASPM	2.60e-03	73	70	3	PS50021
Domain	CH-domain	SPTBN4 DST ASPM	2.81e-03	75	70	3	IPR001715
Domain	Znf_C2H2-like	ZNF708 ZBTB49 ZNF630 ZNF680 ZNF273 MATR3 ZSCAN5C ZNF300 ZIC1	2.81e-03	796	70	9	IPR015880
Domain	ZnF_C2H2	ZNF708 ZBTB49 ZNF630 ZNF680 ZNF273 MATR3 ZSCAN5C ZNF300 ZIC1	3.10e-03	808	70	9	SM00355
Domain	Actinin_actin-bd_CS	SPTBN4 DST	3.33e-03	23	70	2	IPR001589
Domain	Spectrin	SPTBN4 DST	3.33e-03	23	70	2	PF00435
Domain	ACTININ_2	SPTBN4 DST	3.33e-03	23	70	2	PS00020
Domain	ACTININ_1	SPTBN4 DST	3.33e-03	23	70	2	PS00019
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	RPL23A CDC37 NAA15 DST SMC3 CALR MATR3 OTUB1 CLIC4 NCAPH PLOD2 YTHDF2 SCAF4 RPL19	1.02e-07	1149	73	14	35446349
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL23A CDC37 ACSL3 NAA15 DST SMC3 NSA2 UBTF MATR3 RTCA ASPM CLIC4 NCAPH YTHDF2 RPL19	1.14e-07	1353	73	15	29467282
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RPL23A CDC37 SMC3 CALR MORF4L1 MATR3 RTCA GAS8 ASPM MKLN1 MCC NUF2 SSR3 PLOD2	3.93e-07	1284	73	14	17353931
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	RPL23A CDC37 ACSL3 DST SMC3 CALR MORF4L1 OTUB1 CARS1 PLXNB2 PLOD2 DNAJC3 YTHDF2 RPL19	4.43e-07	1297	73	14	33545068
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	RPL23A CDC37 DST NSA2 ASPM CARS1 MASTL CLIC4 SCAF4	6.51e-07	472	73	9	38943005
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	RPL23A CDC37 ACSL3 NAA15 SMC3 CALR MATR3 OTUB1 MCC NCK1 DNAJC3 RPL19	8.32e-07	974	73	12	28675297
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	RPL23A NAA15 SMC3 MATR3 CARS1 MCC NUF2 NCAPH YTHDF2 SCAF4 RPL19	1.51e-06	847	73	11	35235311
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL23A SPTBN4 ACSL3 DST NSA2 NSD2 MATR3 ASPM ANKRD30B SSR3 NCAPH DNAJC3 PALB2 RPL19	1.56e-06	1442	73	14	35575683
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DOCK3 GABRD SPTBN4 TRIM33 DST MORF4L1 MKLN1 CCDC15 CLIC4 RORB NCK1 COG4 SOS2	2.47e-06	1285	73	13	35914814
Pubmed	Structural Insight into the Mechanism of PALB2 Interaction with MRG15.	MORF4L1 PALB2	4.35e-06	2	73	2	34946951
Pubmed	Identification of a novel calreticulin isoform (Crt2) in human and mouse.	CALR3 CALR	4.35e-06	2	73	2	12384296
Pubmed	SCAF4 and SCAF8, mRNA Anti-Terminator Proteins.	SCAF8 SCAF4	4.35e-06	2	73	2	31104839
Pubmed	Calreticulin-2 is localized in the lumen of the endoplasmic reticulum but is not a Ca2+ -binding protein.	CALR3 CALR	4.35e-06	2	73	2	21590275
Pubmed	miRNA-27b modulates endothelial cell angiogenesis by directly targeting Naa15 in atherogenesis.	NAA15 AOPEP	4.35e-06	2	73	2	27755984
Pubmed	Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.	RPL23A CDC37 CLUAP1 MATR3 YTHDF2 RPL19	4.78e-06	205	73	6	28927264
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL23A CDC37 ACSL3 SMC3 CALR NSD2 UBTF MATR3 OTUB1 CARS1 NCAPH DNAH5 RPL19	7.58e-06	1425	73	13	30948266
Pubmed	Human transcription factor protein interaction networks.	CDC37 TRIM33 DST SMC3 NSA2 SCAF8 UBTF MORF4L1 MATR3 ELK4 YTHDF2 SCAF4 RPL19	7.81e-06	1429	73	13	35140242
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RPL23A ACSL3 NAA15 DST CALR NSA2 NSD2 UBTF RPL19	9.14e-06	653	73	9	22586326
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RPL23A ACSL3 DST SMC3 CALR UBTF MATR3 SRC PLXNB2 SCAF4 RPL19	9.17e-06	1024	73	11	24711643
Pubmed	Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization.	SRC NCK1	1.30e-05	3	73	2	16543952
Pubmed	MRG15-mediated tethering of PALB2 to unperturbed chromatin protects active genes from genotoxic stress.	MORF4L1 PALB2	1.30e-05	3	73	2	28673974
Pubmed	YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation.	OTUB1 YTHDF2	1.30e-05	3	73	2	38462165
Pubmed	Structural Basis for Multi-specificity of MRG Domains.	MORF4L1 PALB2	1.30e-05	3	73	2	25960410
Pubmed	Functional interaction of human Cdc37 with the androgen receptor but not with the glucocorticoid receptor.	CDC37 SRC	1.30e-05	3	73	2	11085988
Pubmed	Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II.	SCAF8 SCAF4	1.30e-05	3	73	2	18550522
Pubmed	Structural basis for molecular interactions involving MRG domains: implications in chromatin biology.	MORF4L1 PALB2	1.30e-05	3	73	2	22244764
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL23A ACSL3 DST MLX NSD2 UBTF MORF4L1 MATR3 SSR3 PALB2 SCAF4 RPL19	1.51e-05	1294	73	12	30804502
Pubmed	Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway.	MORF4L1 OTUB1 PALB2	1.52e-05	23	73	3	22038470
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	CDC37 TRIM33 SMC3 RTCA SSR3 NCAPH DNAH5 DNAJC3 YTHDF2	1.66e-05	704	73	9	29955894
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	CDC37 SCAF8 MCC MASTL NCK1 SSR3 COG4 YTHDF2 RPL19	2.28e-05	733	73	9	34672954
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CDC37 NAA15 DST UBTF MATR3 MASTL NCAPH YTHDF2 SCAF4 RPL19	2.50e-05	934	73	10	33916271
Pubmed	Genetic and age related models of neurodegeneration in mice: dystrophic axons.	SPTBN4 DST	2.60e-05	4	73	2	1634998
Pubmed	Kinase-dependent adhesion to fibronectin: regulation by calreticulin.	CALR SRC	2.60e-05	4	73	2	18255058
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NAA15 SMC3 CALR MATR3 BUB1 ASPM MCC MASTL CCDC15 NUF2 PLOD2	2.79e-05	1155	73	11	20360068
Pubmed	CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.	RPL23A ACSL3 CALR UBTF DNAJC3 YTHDF2 RPL19	2.84e-05	418	73	7	35338135
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RPL23A SMC3 NSA2 NSD2 UBTF MATR3 ASPM YTHDF2 RPL19	2.99e-05	759	73	9	35915203
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	RPL23A NSA2 MORF4L1 MATR3 RTCA BUB1 ASPM SSR3 YTHDF2 RPL19	3.47e-05	971	73	10	33306668
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	RPL23A CDC37 DST MCC MASTL RASSF3 RPL19	3.50e-05	432	73	7	23455922
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RPL23A TRIM33 SMC3 NSA2 UBTF MORF4L1 MATR3 OTUB1 CLIC4 RPL19	4.06e-05	989	73	10	36424410
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF708 ZNF680 ZNF273 MKLN1 YTHDF2	4.07e-05	181	73	5	37372979
Pubmed	Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.	SRC NCK1	4.33e-05	5	73	2	9032297
Pubmed	HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma.	PLXNB2 YTHDF2	4.33e-05	5	73	2	36423520
Pubmed	Loss-of-Function GAS8 Mutations Cause Primary Ciliary Dyskinesia and Disrupt the Nexin-Dynein Regulatory Complex.	GAS8 DNAH5	4.33e-05	5	73	2	26387594
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	DOCK3 DST MORF4L1 MATR3	4.34e-05	92	73	4	15840729
Pubmed	Lynch Syndrome	SRC BUB1 MCC	4.63e-05	33	73	3	20301390
Pubmed	Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy.	RPL23A ACSL3 NAA15 DST UBTF CARS1 RPL19	4.78e-05	454	73	7	33226137
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	SMC3 NSD2 UBTF MATR3 NCAPH	5.80e-05	195	73	5	19454010
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL23A CDC37 NAA15 DST SMC3 NSA2 UBTF MATR3 NCAPH YTHDF2 RPL19	6.00e-05	1257	73	11	36526897
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	DST SMC3 CALR OTUB1 MCC COG4	6.08e-05	322	73	6	26514267
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	CDC37 DST SMC3 PLOD2 YTHDF2	6.09e-05	197	73	5	20811636
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	CLPP RPL23A CDC37 ACSL3 NAA15 DST MLX NSA2 MATR3 BUB1 NUF2 PLXNB2	6.20e-05	1496	73	12	32877691
Pubmed	Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1.	SRC NCK1	6.48e-05	6	73	2	12091389
Pubmed	Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.	RPL23A SMC3 MATR3 RPL19	6.50e-05	102	73	4	26584622
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	RPL23A ACSL3 DST SMC3 CALR MATR3 RPL19	6.52e-05	477	73	7	31300519
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RPL23A NAA15 DST SCAF8 BUB1 SSR3 COG4 YTHDF2	6.59e-05	650	73	8	38777146
Pubmed	Charting the molecular links between driver and susceptibility genes in colorectal cancer.	AOPEP SRC BUB1 MCC	7.83e-05	107	73	4	24412244
Pubmed	Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer.	CDC37 CALR	9.06e-05	7	73	2	30108113
Pubmed	SH3 binding domains in the dopamine D4 receptor.	SRC NCK1	9.06e-05	7	73	2	9843378
Pubmed	Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins.	SRC NCK1	9.06e-05	7	73	2	11724572
Pubmed	The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.	SRC NCK1	9.06e-05	7	73	2	10829062
Pubmed	Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice.	MORF4L1 PALB2	9.06e-05	7	73	2	25016020
Pubmed	Identification of a ten-amino acid proline-rich SH3 binding site.	SRC NCK1	9.06e-05	7	73	2	8438166
Pubmed	Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF.	SRC NCK1	9.06e-05	7	73	2	16966330
Pubmed	PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function.	MORF4L1 PALB2	9.06e-05	7	73	2	22331464
Pubmed	Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1.	SRC NCK1	9.06e-05	7	73	2	10391903
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	CDC37 ACSL3 NAA15 CALR OTUB1 CARS1 CLIC4 PLOD2 COG4	9.15e-05	878	73	9	37223481
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TRIM33 SMC3 UBTF MATR3 OTUB1	1.02e-04	220	73	5	35785414
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	SPTBN4 CDC37 CALR MATR3 SRC OTUB1 MCC NCK1 PLXNB2 COG4	1.17e-04	1124	73	10	21900206
Pubmed	The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.	BUB1 ASPM NUF2 SKA1 NCAPH	1.19e-04	227	73	5	26410627
Pubmed	The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation.	SRC NCK1	1.21e-04	8	73	2	21309750
Pubmed	Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity.	CDC37 SRC	1.21e-04	8	73	2	22315411
Pubmed	c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts.	SRC NCK1	1.21e-04	8	73	2	8635998
Pubmed	Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma.	SRC NCK1	1.21e-04	8	73	2	18296648
Pubmed	ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair.	MORF4L1 PALB2	1.21e-04	8	73	2	22193777
Pubmed	The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association.	ACSL3 SRC	1.21e-04	8	73	2	20605918
Pubmed	Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination.	MORF4L1 PALB2	1.21e-04	8	73	2	23585894
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	CLPP DOCK3 CDC37 SMC3 CALR NCK1 SSR3 PLOD2 SOS2	1.26e-04	916	73	9	32203420
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DST UBTF MATR3 ASPM DNAH5	1.37e-04	234	73	5	36243803
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	RPL23A SMC3 CALR MATR3 RTCA SSR3 YTHDF2 RPL19	1.40e-04	725	73	8	27025967
Pubmed	Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis.	SRC NCK1	1.55e-04	9	73	2	16636290
Pubmed	Artemin activates axonal growth via SFK and ERK-dependent signalling pathways in mature dorsal root ganglia neurons.	SRC NCK1	1.55e-04	9	73	2	17868192
Pubmed	Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck.	SRC NCK1	1.55e-04	9	73	2	10428862
Pubmed	HSF2BP Interacts with a Conserved Domain of BRCA2 and Is Required for Mouse Spermatogenesis.	MORF4L1 PALB2	1.55e-04	9	73	2	31242413
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	RPL23A SMC3 CALR MATR3 CLIC4 RPL19	1.90e-04	397	73	6	21319273
Pubmed	Functional modifications of acid-sensing ion channels by ligand-gated chloride channels.	GABRD ASIC2	1.93e-04	10	73	2	21789198
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CDC37 ACSL3 DST CALR NSA2 UBTF OTUB1 NCAPH PLOD2 COG4 YTHDF2	1.98e-04	1440	73	11	30833792
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CDC37 ACSL3 CALR MCC SKA1 PLXNB2 DNAJC3	2.02e-04	573	73	7	28330616
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CLPP RPL23A ACSL3 GVINP1 CALR MATR3 SSR3 PLXNB2 PLOD2 DNAJC3 RPL19	2.12e-04	1451	73	11	30550785
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SMC3 SCAF8 MORF4L1 BUB1 NUF2 SFI1 NCAPH	2.22e-04	582	73	7	20467437
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	RPL23A UBTF MATR3 YTHDF2 RPL19	2.23e-04	260	73	5	36199071
Pubmed	Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome.	DOCK3 SRC NCK1	2.27e-04	56	73	3	22745667
Pubmed	APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.	SMC3 PALB2	2.36e-04	11	73	2	22293751
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CLPP CDC37 ACSL3 NAA15 CALR UBTF OTUB1 ASPM PLXNB2 PLOD2 DNAJC3	2.62e-04	1487	73	11	33957083
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	RPL23A ACSL3 NAA15 SMC3 CALR PLOD2	2.64e-04	422	73	6	27342126
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SPTBN4 ZNF708 AOPEP NSD2 SCAF8 SRC MKLN1 RASSF3 ELK4 DNAJC3 SOS2	2.65e-04	1489	73	11	28611215
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CDC37 TRIM33 SMC3 NSD2 UBTF MATR3 RTCA OTUB1 NCAPH	2.68e-04	1014	73	9	32416067
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RPL23A UBTF MATR3 OTUB1 SSR3 YTHDF2 RPL19	2.70e-04	601	73	7	33658012
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	CDC37 TRIM33 MLX CALR UBTF OTUB1	2.74e-04	425	73	6	24999758
Pubmed	MRG15 is a novel PALB2-interacting factor involved in homologous recombination.	MORF4L1 PALB2	2.83e-04	12	73	2	19553677
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF680 SMC3 CALR NSD2 UBTF MORF4L1 MASTL	2.90e-04	608	73	7	36089195
Interaction	SEC61B interactions	CLPP RPL23A ACSL3 CLUAP1 CALR3 CALR OTUB1 BUB1 MCC SSR3 PLXNB2 PLOD2 DNAJC3 RPL19	3.59e-07	763	71	14	int:SEC61B
Interaction	PRKCSH interactions	CDC37 TRIM33 CALR3 CALR MATR3 NCAPH DNAJC3 SCAF4	3.34e-06	257	71	8	int:PRKCSH
Interaction	MERTK interactions	CDC37 ACSL3 SMC3 CALR RASSF3 YTHDF2	9.98e-06	140	71	6	int:MERTK
Interaction	TRIM28 interactions	CDC37 TRIM33 ZNF708 ZNF680 SMC3 ZNF273 NSD2 MATR3 SRC RTCA OTUB1 MKLN1 SSR3 NCAPH DNAH5 DNAJC3 YTHDF2	1.04e-05	1474	71	17	int:TRIM28
Interaction	KTN1 interactions	CDC37 TRIM33 DST NUF2 SSR3 NCAPH DNAJC3 RPL19	2.11e-05	331	71	8	int:KTN1
Interaction	PRPSAP2 interactions	CLPP NSD2 NCK1 ELK4 RPL19	3.01e-05	102	71	5	int:PRPSAP2
Interaction	ZNF189 interactions	RPL23A SRC BUB1 MCC	3.12e-05	51	71	4	int:ZNF189
Interaction	ZNF543 interactions	ZNF708 UBTF MCC	5.32e-05	21	71	3	int:ZNF543
Interaction	MSANTD3 interactions	SMC3 BUB1 MCC	5.32e-05	21	71	3	int:MSANTD3
Interaction	MST1R interactions	CDC37 SMC3 SRC CCDC168 NCAPH RPL19	7.42e-05	200	71	6	int:MST1R
Interaction	HSPA4 interactions	CLPP CDC37 TRIM33 MORF4L1 SRC OTUB1 ASPM CARS1 NUF2 DNAJC3	1.10e-04	667	71	10	int:HSPA4
Interaction	NCAPH interactions	RPL23A CALR MATR3 ASPM NCAPH YTHDF2 RPL19	1.20e-04	315	71	7	int:NCAPH
Interaction	USP15 interactions	RPL23A CDC37 SMC3 MATR3 OTUB1 MKLN1 NCAPH PLOD2 RPL19	1.23e-04	546	71	9	int:USP15
Interaction	BAAT interactions	SRC BUB1 MCC	1.29e-04	28	71	3	int:BAAT
Interaction	SPC24 interactions	BUB1 ASPM NUF2 SKA1	1.66e-04	78	71	4	int:SPC24
Interaction	BAP1 interactions	RPL23A CDC37 NAA15 DST SMC3 CALR MATR3 OTUB1 CLIC4 NCAPH PLOD2 YTHDF2 SCAF4 RPL19	1.69e-04	1314	71	14	int:BAP1
Interaction	ELF5 interactions	RPL23A TRIM33 SMC3 MATR3 RPL19	1.71e-04	147	71	5	int:ELF5
Interaction	RPL38 interactions	RPL23A DST GVINP1 NSD2 SSR3 NCAPH RPL19	1.73e-04	334	71	7	int:RPL38
Interaction	CCDC180 interactions	SRC BUB1 MCC	1.75e-04	31	71	3	int:CCDC180
Interaction	CALU interactions	TRIM33 CLUAP1 CALR3 CALR ASPM PLOD2 DNAJC3	1.79e-04	336	71	7	int:CALU
Interaction	TXLNA interactions	CDC37 DST OTUB1 GAS8 MCC PLOD2	1.84e-04	236	71	6	int:TXLNA
Interaction	MAD1L1 interactions	CDC37 KIF9 MLX UBTF GAS8	1.87e-04	150	71	5	int:MAD1L1
Interaction	CDC5L interactions	RPL23A DST SMC3 SCAF8 UBTF MORF4L1 MATR3 BUB1 NUF2 SFI1 NCAPH	1.87e-04	855	71	11	int:CDC5L
Interaction	CTNNB1 interactions	RPL23A CDC37 TRIM33 NAA15 DST NSD2 MATR3 SRC OTUB1 ASPM NCAPH YTHDF2	1.93e-04	1009	71	12	int:CTNNB1
Interaction	RNF2 interactions	RPL23A SMC3 CALR NSA2 UBTF MORF4L1 MATR3 OTUB1 NCAPH YTHDF2 RPL19	2.09e-04	866	71	11	int:RNF2
Interaction	TRMO interactions	SRC BUB1 MCC	2.12e-04	33	71	3	int:TRMO
Interaction	MAGEB2 interactions	RPL23A CALR NSA2 NSD2 UBTF SCAF4 RPL19	2.26e-04	349	71	7	int:MAGEB2
Interaction	RCN1 interactions	TRIM33 CALR3 CALR MATR3 ASPM DNAJC3	2.51e-04	250	71	6	int:RCN1
Interaction	ZWINT interactions	CDC37 BUB1 MASTL NUF2 SSR3	2.53e-04	160	71	5	int:ZWINT
Interaction	PPIA interactions	RPL23A CDC37 DST NSA2 NSD2 ASPM CARS1 MASTL CLIC4 YTHDF2 SCAF4	2.60e-04	888	71	11	int:PPIA
Interaction	SIRT7 interactions	RPL23A ACSL3 NAA15 DST CALR NSA2 NSD2 UBTF ELK4 RPL19	2.67e-04	744	71	10	int:SIRT7
Interaction	ALDOB interactions	SRC BUB1 MCC	2.75e-04	36	71	3	int:ALDOB
Interaction	ASPM interactions	CLUAP1 CALR ASPM SSR3 NCAPH	2.83e-04	164	71	5	int:ASPM
Interaction	SSB interactions	RPL23A CDC37 TRIM33 DST SMC3 CALR OTUB1 RPL19	2.95e-04	484	71	8	int:SSB
Interaction	HIPK4 interactions	CDC37 ACSL3 YTHDF2	2.99e-04	37	71	3	int:HIPK4
Interaction	MRFAP1 interactions	CLUAP1 MORF4L1 OTUB1 PALB2	3.00e-04	91	71	4	int:MRFAP1
Interaction	DNAJC10 interactions	CLPP TRIM33 CALR3 CALR DNAJC3 SCAF4	3.09e-04	260	71	6	int:DNAJC10
Interaction	GANAB interactions	TRIM33 CALR3 CALR MATR3 NCAPH PLOD2 DNAJC3	3.12e-04	368	71	7	int:GANAB
Interaction	RPL10A interactions	RPL23A DST NSA2 MATR3 NCK1 SSR3 NCAPH RPL19	3.20e-04	490	71	8	int:RPL10A
Interaction	ZBTB26 interactions	CDC37 MORF4L1 GAS8	3.24e-04	38	71	3	int:ZBTB26
Interaction	BEND7 interactions	CDC37 MLX PLEKHF2 MORF4L1	3.40e-04	94	71	4	int:BEND7
Interaction	CALM1 interactions	DOCK3 TRIM33 DST CALR MORF4L1 MATR3 SRC ASPM SFI1	3.40e-04	626	71	9	int:CALM1
Interaction	DCTN1 interactions	CDC37 NAA15 DST MATR3 NUF2 SKA1 NCAPH YTHDF2	3.52e-04	497	71	8	int:DCTN1
Interaction	CEP78 interactions	TRIM33 CALR ASPM MCC	3.68e-04	96	71	4	int:CEP78
Interaction	BRCA1 interactions	RPL23A CDC37 TRIM33 NAA15 DST SMC3 NSD2 UBTF MORF4L1 MATR3 CARS1 ELK4 PALB2	3.74e-04	1249	71	13	int:BRCA1
Interaction	ALK interactions	CDC37 ACSL3 SRC NCK1 SSR3 DNAJC3	3.85e-04	271	71	6	int:ALK
Interaction	FLT4 interactions	CDC37 ACSL3 SMC3 CALR NCK1 NCAPH	3.93e-04	272	71	6	int:FLT4
Interaction	KARS1 interactions	PLEKHF2 SRC OTUB1 CARS1 NCAPH PLOD2 RPL19	3.96e-04	383	71	7	int:KARS1
Interaction	CDK2 interactions	RPL23A CDC37 DST SMC3 CALR UBTF MATR3 BUB1 CLIC4 RPL19	4.00e-04	783	71	10	int:CDK2
Interaction	NCAPG2 interactions	CLPP CLUAP1 ASPM NCAPH	4.30e-04	100	71	4	int:NCAPG2
Interaction	RPS20 interactions	RPL23A NAA15 OTUB1 SSR3 NCAPH COG4 YTHDF2 RPL19	4.35e-04	513	71	8	int:RPS20
Interaction	CEBPB interactions	RPL23A CDC37 NAA15 SMC3 CALR NSA2 UBTF MATR3 OTUB1 ASPM NCAPH YTHDF2 SCAF4 RPL19	4.41e-04	1443	71	14	int:CEBPB
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF708 ZBTB49 ZNF630 ZNF680 ZNF273 ZSCAN5C ZNF300 ZIC1	7.29e-04	718	50	8	28
Coexpression	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	NSD2 BUB1 ASPM NUF2 SSR3 NCAPH PLOD2	3.50e-07	162	73	7	M6387
Coexpression	FISCHER_DREAM_TARGETS	ZNF680 NAA15 SMC3 ZNF273 NSD2 BUB1 ASPM MASTL CCDC15 CLIC4 NUF2 SKA1 NCAPH PALB2	3.93e-07	969	73	14	M149
Coexpression	GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP	DST BUB1 ASPM NUF2 NCAPH PLXNB2 PLOD2	6.13e-07	176	73	7	M2981
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	NAA15 SMC3 ZNF273 BUB1 ASPM MASTL NCK1 NUF2 ELK4 SSR3 NCAPH DNAJC3 YTHDF2	8.13e-07	877	73	13	M2241
Coexpression	ZHONG_PFC_C3_UNKNOWN_INP	BUB1 NUF2 SKA1 NCAPH	3.80e-06	38	73	4	M39083
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	NAA15 SMC3 NSD2 BUB1 ASPM NCAPH PALB2	6.29e-06	250	73	7	M11318
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	NSD2 BUB1 ASPM CLIC4 NUF2 PLOD2	1.23e-05	183	73	6	M2993
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	BUB1 ASPM MCC NUF2 SKA1 NCAPH	1.52e-05	190	73	6	M761
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	ZNF273 SCAF8 RTCA BUB1 MCC PLXNB2	1.87e-05	197	73	6	M5210
Coexpression	WHITEFORD_PEDIATRIC_CANCER_MARKERS	NSD2 BUB1 ZNF300 NUF2 NCAPH	1.92e-05	117	73	5	M7854
Coexpression	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP	RTCA BUB1 ASPM NUF2 SKA1 NCAPH	1.98e-05	199	73	6	M8277
Coexpression	GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN	NSD2 RTCA BUB1 MASTL NUF2 SKA1	2.04e-05	200	73	6	M6417
Coexpression	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	BUB1 ASPM RASSF3 NUF2 SKA1 NCAPH	2.04e-05	200	73	6	M3580
Coexpression	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	2.04e-05	200	73	6	M3577
Coexpression	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SMC3 MATR3 BUB1 ASPM MASTL RASSF3 NUF2 SKA1 NCAPH PALB2	2.79e-05	714	73	10	M1744
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	NAA15 SMC3 MATR3 RTCA ASPM CARS1 CLIC4 NUF2 SSR3 ZIC1	3.03e-05	721	73	10	M10237
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL	RPL23A BUB1 ASPM MASTL NUF2 NCAPH PLOD2	3.22e-05	322	73	7	M39060
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	ZNF680 MLX SMC3 NSD2 PLEKHF2 MATR3 RTCA BUB1 ASPM MASTL NUF2 SKA1 NCAPH	5.13e-05	1290	73	13	M80
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	NAA15 SMC3 MATR3 RTCA CARS1 MKLN1 MASTL CLIC4 SSR3	7.38e-05	644	73	9	M10501
Coexpression	BENPORATH_NANOG_TARGETS	KIF9 CALR MORF4L1 OTUB1 MCC ZNF300 CLIC4 SFI1 PALB2 ZIC1 SCAF4	8.66e-05	988	73	11	M6616
Coexpression	SEIDEN_ONCOGENESIS_BY_MET	NSA2 RTCA CLIC4 PLOD2	1.13e-04	89	73	4	M3231
Coexpression	GAVIN_FOXP3_TARGETS_CLUSTER_P6	ST8SIA6 BUB1 ASPM NUF2	1.34e-04	93	73	4	M1735
Coexpression	DE_YY1_TARGETS_DN	NAA15 DST CLIC4 RASSF3	1.34e-04	93	73	4	M3278
Coexpression	GAVIN_FOXP3_TARGETS_CLUSTER_P6	ST8SIA6 BUB1 ASPM NUF2	1.46e-04	95	73	4	MM1217
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	DST ZNF273 NSD2 PLEKHF2 ASPM CCDC15 NUF2 SKA1 NCAPH DNAJC3	1.77e-04	892	73	10	M18120
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	BUB1 ASPM NUF2 SKA1 NCAPH	1.78e-04	187	73	5	M2984
Coexpression	PUJANA_BRCA2_PCC_NETWORK	SMC3 ZNF273 NSD2 RTCA BUB1 NCK1 NCAPH	1.85e-04	426	73	7	M9516
Coexpression	FUJII_YBX1_TARGETS_DN	NSD2 ASPM MASTL NCAPH DNAJC3	2.11e-04	194	73	5	M14340
Coexpression	YU_MYC_TARGETS_UP	BUB1 ASPM CLIC4	2.20e-04	42	73	3	MM1150
Coexpression	GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN	RPL23A UBTF ZNF300 RASSF3 ELK4	2.26e-04	197	73	5	M6525
Coexpression	YU_MYC_TARGETS_UP	BUB1 ASPM CLIC4	2.36e-04	43	73	3	M1249
Coexpression	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	NSD2 ASPM CLIC4 NUF2 SKA1	2.37e-04	199	73	5	M6198
Coexpression	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP	NSA2 RASSF3 SFI1 PLXNB2 DNAJC3	2.43e-04	200	73	5	M9478
Coexpression	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP	BUB1 ASPM NUF2 SKA1 NCAPH	2.43e-04	200	73	5	M5041
Coexpression	GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP	GABRD CLIC4 NCK1 DNAH5 SOS2	2.43e-04	200	73	5	M9381
Coexpression	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN	CLUAP1 NSD2 RTCA NCK1 RPL19	2.43e-04	200	73	5	M5005
Coexpression	GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	MKLN1 CLIC4 NCK1 SSR3 PLXNB2	2.43e-04	200	73	5	M9653
Coexpression	GSE3982_MAC_VS_BASOPHIL_UP	DOCK3 ACSL3 RTCA MKLN1 SSR3	2.43e-04	200	73	5	M5496
Coexpression	GSE17721_CTRL_VS_LPS_6H_BMDC_UP	SMC3 MATR3 RASSF3 PLXNB2 RPL19	2.43e-04	200	73	5	M3691
Coexpression	GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN	BUB1 ASPM NUF2 SKA1 PLOD2	2.43e-04	200	73	5	M9277
Coexpression	LEE_EARLY_T_LYMPHOCYTE_UP	NSD2 BUB1 ASPM NUF2	2.65e-04	111	73	4	M7357
Coexpression	FAELT_B_CLL_WITH_VH3_21_UP	CALR UBTF SRC	2.70e-04	45	73	3	M15164
Coexpression	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	NSD2 RTCA BUB1 ASPM SKA1 NCAPH PLOD2	2.87e-04	458	73	7	M8520
Coexpression	ZHAN_MULTIPLE_MYELOMA_PR_UP	ASPM NUF2 SKA1	2.89e-04	46	73	3	M4888
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	3.71e-04	478	73	7	M45785
Coexpression	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	CALR BUB1 ASPM NUF2	3.79e-04	122	73	4	M18550
Coexpression	BIDUS_METASTASIS_UP	NSD2 BUB1 CCDC15 NCAPH PLOD2	3.84e-04	221	73	5	M15866
Coexpression	HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL	BUB1 ASPM CCDC15 NUF2 NCAPH	3.84e-04	221	73	5	M45789
Coexpression	VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP	BUB1 ASPM SKA1 NCAPH	4.42e-04	127	73	4	M40952
Coexpression	KANG_DOXORUBICIN_RESISTANCE_UP	NSD2 BUB1 ASPM	4.64e-04	54	73	3	M1037
Coexpression	FAN_EMBRYONIC_CTX_NSC_2	BUB1 ASPM NUF2 SKA1 NCAPH	4.89e-04	233	73	5	M39036
Coexpression	ZHONG_PFC_C1_OPC	BUB1 ASPM NUF2 SKA1 NCAPH	5.38e-04	238	73	5	M39096
Coexpression	DELACROIX_RARG_BOUND_MEF	CLPP DST CALR SRC GAS8 RPL19	5.51e-04	366	73	6	M2461
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NSD2 BUB1 ASPM MASTL CCDC15 NUF2 SKA1 NCAPH	1.19e-09	196	73	8	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1 ASPM MASTL CCDC168 NUF2 SKA1 NCAPH	1.57e-08	175	73	7	d43ae33a6256606ce848247cad32d74f21b38988
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasmablasts\|Liver / Manually curated celltypes from each tissue	BUB1 ASPM CLIC4 NUF2 SSR3 SKA1 NCAPH	1.69e-08	177	73	7	1d88ae316d65ca5fdc736c9da93885b6b40c32bb
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	1.83e-08	179	73	7	54191c00b29f53b520cd3243b5791daa4a2c72d7
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL RASSF3 NUF2 SKA1 NCAPH	2.05e-08	182	73	7	bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL RASSF3 NUF2 SKA1 NCAPH	2.05e-08	182	73	7	0fc45214f0b0766f69be6eff69cc4bec574023aa
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NSD2 BUB1 ASPM MASTL CCDC15 NUF2 NCAPH	2.66e-08	189	73	7	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	2.76e-08	190	73	7	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	Mild-T/NK_proliferative\|World / Disease group and Cell class	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	2.86e-08	191	73	7	9dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CALR BUB1 ASPM NUF2 SSR3 SKA1 NCAPH	2.97e-08	192	73	7	b9c606547c303a099a653169923a44c20816a604
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NSD2 BUB1 ASPM CCDC15 NUF2 SKA1 NCAPH	3.07e-08	193	73	7	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	3.30e-08	195	73	7	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.30e-08	195	73	7	043e2f19d95e94cd5219e2c415f322ed340aa80f
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	3.42e-08	196	73	7	20383d576708b7e4bfce3e9fe40548cce496e3cb
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSD2 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	3.42e-08	196	73	7	0644bd14a944b9c9759a295dfdd5e67a4775f20a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL CCDC15 NUF2 SKA1 NCAPH	3.54e-08	197	73	7	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL CCDC15 NUF2 SKA1 NCAPH	3.54e-08	197	73	7	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	MATR3 BUB1 ASPM MASTL NUF2 SKA1 NCAPH	3.79e-08	199	73	7	3d876f172487425b37b2f658dae59e0f293ee76e
ToppCell	tumor_Lung-T/NK_cells-Undetermined\|tumor_Lung / Location, Cell class and cell subclass	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.79e-08	199	73	7	2e222e2e080bc2be63d0fdf285e1790676b911ef
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NSD2 BUB1 ASPM CCDC15 NUF2 SKA1 NCAPH	3.79e-08	199	73	7	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts\|lymph-node_spleen / Manually curated celltypes from each tissue	CALR BUB1 ASPM NUF2 SSR3 SKA1 NCAPH	3.92e-08	200	73	7	b0d708715f09ec1f67fdef3b100a91c8ff2747a7
ToppCell	Severe-T/NK_proliferative\|Severe / Disease group and Cell class	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.92e-08	200	73	7	4723613a9f56bff422fc98722128d57b6adf3c5d
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.92e-08	200	73	7	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.92e-08	200	73	7	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.92e-08	200	73	7	f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SMC3 NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	3.92e-08	200	73	7	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRD BUB1 ASPM NUF2 SKA1 DNAH5	2.98e-07	164	73	6	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRD BUB1 ASPM NUF2 SKA1 DNAH5	2.98e-07	164	73	6	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	Dividing_Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ZNF680 BUB1 ASPM NUF2 SKA1 NCAPH	3.20e-07	166	73	6	c503036f3c19ef186e1e62c9643c49dea3827f51
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BUB1 ASPM CCDC15 NUF2 SKA1 NCAPH	3.31e-07	167	73	6	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1 ASPM MASTL NUF2 SKA1 PALB2	3.31e-07	167	73	6	d21635df8b74189e3309eaf435af381fbe412574
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STAB2 BUB1 ASPM NUF2 SKA1 PALB2	3.68e-07	170	73	6	b04e2f84024baaae9b4ff19bdac8c69afdb92a76
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GABRD RXFP2 BUB1 ASPM CCDC15 NCAPH	3.81e-07	171	73	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GABRD RXFP2 BUB1 ASPM CCDC15 NCAPH	3.81e-07	171	73	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	Dividing_Macrophages-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	BUB1 ASPM CCDC168 NUF2 SKA1 NCAPH	4.36e-07	175	73	6	0a8bf455babb3271aa00642199fb58b0b02dc3ac
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	4.98e-07	179	73	6	dabecd283c1f0f71a66b804c99be8bd48ea36e35
ToppCell	Control-Developping_Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	4.98e-07	179	73	6	9383568f78b07b8cca72ece5d15fea209aa54ea9
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	5.14e-07	180	73	6	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	5.14e-07	180	73	6	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	5.31e-07	181	73	6	cf13bf7a531a2d40f8d778629cf2431b684f65f3
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	5.31e-07	181	73	6	74311aac2fe27dc02a9be3bc20e0c7ef1c239049
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	SMC3 BUB1 ASPM NUF2 SKA1 NCAPH	5.66e-07	183	73	6	a48a6313f2f144586951cece97ec31f6d72361df
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	5.66e-07	183	73	6	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	ZNF273 NSD2 MATR3 BUB1 ASPM NCAPH	5.85e-07	184	73	6	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	ZNF273 NSD2 MATR3 BUB1 ASPM NCAPH	5.85e-07	184	73	6	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.03e-07	185	73	6	0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.03e-07	185	73	6	89b85ce8026dc80c1bd9f76dfe16401c173b7946
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	6.03e-07	185	73	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.23e-07	186	73	6	9feef5936985e936b3d88f9d1bb012abb6468570
ToppCell	facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.23e-07	186	73	6	89f5b06bc56674af304912d481ac697c7c870904
ToppCell	COVID-19_Mild-Neu_4\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	RPL23A SMC3 NSD2 ASPM MASTL RPL19	6.43e-07	187	73	6	714851e757c71c559ee6413a3f61d6c117c79ad2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	6.43e-07	187	73	6	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	6.43e-07	187	73	6	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BUB1 ASPM CCDC15 CCDC168 NUF2 NCAPH	6.63e-07	188	73	6	319fbeca200ab998daf49fcaee0bfdb57bf7ee4b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.63e-07	188	73	6	95d0a796d62ce6d121e2028c378faffc14b35275
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasmablasts\|bone_marrow / Manually curated celltypes from each tissue	CALR BUB1 CLIC4 NUF2 SSR3 SKA1	6.63e-07	188	73	6	4caae2acd9ec0eb79b7476a1e59f30f39afddcda
ToppCell	facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.84e-07	189	73	6	bfa3ed1360991a3e32fad133017c413f8adc1eba
ToppCell	facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	6.84e-07	189	73	6	96f10c63656e446b4bb712f012e91ae986f8c2d0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BUB1 ASPM CCDC15 NUF2 SKA1 NCAPH	7.05e-07	190	73	6	31de1727822e9818652946dfb962daee77ffad68
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.27e-07	191	73	6	15dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.27e-07	191	73	6	239300ff76f2c855b2b04d3002461158be90a01b
ToppCell	Endothelial-D_(cycle)\|World / shred on cell class and cell subclass (v4)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.27e-07	191	73	6	49a4d8f181558e3be9527a8ff9a178f3bb01323c
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	BUB1 ASPM CCDC15 NUF2 SKA1 NCAPH	7.27e-07	191	73	6	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	SMC3 BUB1 ASPM NUF2 SKA1 NCAPH	7.27e-07	191	73	6	210a0f1a71df2508cbfc73d6868a2122338b9a1c
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DOCK3 BUB1 ASPM NUF2 SKA1 NCAPH	7.27e-07	191	73	6	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.27e-07	191	73	6	45c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCell	Endothelial-Endothelial-D_(cycle)\|Endothelial / shred on cell class and cell subclass (v4)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.27e-07	191	73	6	a3c5a913a99f17633c140ec9ece81b73e59e0715
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BUB1 ASPM CCDC15 NUF2 SKA1 NCAPH	7.27e-07	191	73	6	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.50e-07	192	73	6	27723f4e320e49d4a3daafa2d8d3946ff79fab64
ToppCell	droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.50e-07	192	73	6	96f23d6e8604d1cb24910d3118d8171b57c93e14
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.50e-07	192	73	6	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	Proliferating\|World / shred by cell class for mouse tongue	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.50e-07	192	73	6	f081f3f957cc782294e118fcc1055f6a4264ee98
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.73e-07	193	73	6	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	droplet-Tongue-nan-24m-Epithelial-proliferating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.73e-07	193	73	6	f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2
ToppCell	control-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.73e-07	193	73	6	ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.96e-07	194	73	6	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.96e-07	194	73	6	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.96e-07	194	73	6	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.96e-07	194	73	6	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.96e-07	194	73	6	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.96e-07	194	73	6	4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	7.96e-07	194	73	6	3a49c7c86036e09a8cd0114988380d04ad1a26fb
ToppCell	control-Lymphocytic-Prol._cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.96e-07	194	73	6	4c76508de3291c952386caffda2d559629ba5998
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	7.96e-07	194	73	6	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.21e-07	195	73	6	79ee423df85aa1631b7bdea74eacaf826dfc4a2c
ToppCell	Dividing_cells-Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.21e-07	195	73	6	19829760dfcc0edafd2a2bd80f424a45d039af1f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts\|lymph-node_spleen / Manually curated celltypes from each tissue	BUB1 ASPM NUF2 SSR3 SKA1 NCAPH	8.21e-07	195	73	6	1390728b9a514db534e8bc6dcf72cf51a1065780
ToppCell	facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 BUB1 ASPM MASTL NUF2 NCAPH	8.21e-07	195	73	6	93c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.21e-07	195	73	6	294c74336fafc1bad237d851efb4a487475078eb
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.21e-07	195	73	6	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-proliferating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.21e-07	195	73	6	b57132802cb977551e214880984f3edcd375474f
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.21e-07	195	73	6	5790b47b0e028e49b99bda8d6d9e80ac79208cdf
ToppCell	mild-Lymphocytic-Prol._cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.21e-07	195	73	6	9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.21e-07	195	73	6	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.21e-07	195	73	6	5749ea833be84e262e3d0a4fe1a9a373f0ef545f
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.45e-07	196	73	6	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.45e-07	196	73	6	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	mild-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.45e-07	196	73	6	b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BUB1 ASPM MASTL NUF2 SKA1 NCAPH	8.45e-07	196	73	6	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	control-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	NSD2 BUB1 ASPM NUF2 SKA1 NCAPH	8.45e-07	196	73	6	886f7c865b086d6ebb4a1746865c30af6bbed345
Computational	Neighborhood of CDC20	NSD2 BUB1 ASPM NCAPH	9.16e-05	56	46	4	GNF2_CDC20
Computational	Neighborhood of CCNB2	NSD2 BUB1 ASPM NCAPH	9.82e-05	57	46	4	GNF2_CCNB2
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	TRIM33 SCAF8 PLEKHF2 ASPM NCK1 ZIC1 SOS2	2.09e-06	184	73	7	2321_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NSD2 UBTF SRC ELK4 SKA1 ZIC1	2.46e-05	180	73	6	4821_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ACSL3 TRIM33 SCAF8 ASPM NCK1 SOS2	2.62e-05	182	73	6	3887_DN
Drug	d 266	UBTF POMC	3.04e-05	3	73	2	CID000048178
Drug	Alsterpaullone; Down 200; 10uM; MCF7; HT_HG-U133A	TRIM33 SCAF8 PLEKHF2 ASPM NCK1 NCAPH	3.05e-05	187	73	6	7051_DN
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	TRIM33 ZNF273 PLEKHF2 NCK1 PALB2 ZIC1	3.15e-05	188	73	6	3291_DN
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	NSD2 UBTF OTUB1 BUB1 MCC SOS2	3.24e-05	189	73	6	6717_DN
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A	CLUAP1 ZNF273 MATR3 SSR3 NCAPH DNAJC3	3.44e-05	191	73	6	1418_DN
Disease	primary autosomal recessive microcephaly (is_implicated_in)	BUB1 ASPM NCAPH	7.31e-06	16	71	3	DOID:0070296 (is_implicated_in)
Disease	syndrome (implicated_via_orthology)	NSD2 SCAF8 SCAF4	1.06e-05	18	71	3	DOID:225 (implicated_via_orthology)
Disease	Liver carcinoma	GABRD STAB2 BUB1 ASPM NUF2 SKA1 NCAPH YTHDF2	2.96e-05	507	71	8	C2239176
Disease	Colorectal cancer	SRC BUB1 MCC	3.75e-05	27	71	3	cv:C0346629
Disease	COLORECTAL CANCER	SRC BUB1 MCC	3.75e-05	27	71	3	114500
Disease	Neoplasm of the large intestine	SRC BUB1 MCC	3.75e-05	27	71	3	cv:C0009404
Disease	factor VIII measurement, coagulation factor measurement	STAB2 ASIC2	5.68e-05	5	71	2	EFO_0004630, EFO_0004634
Disease	Neurodevelopmental delay	NSD2 CARS1	1.19e-04	7	71	2	C4022738
Disease	developmental disorder of mental health (implicated_via_orthology)	GABRD NAA15 PLXNB2	2.27e-04	49	71	3	DOID:0060037 (implicated_via_orthology)
Disease	phenylacetylglutamine measurement	SRC RXFP2	3.71e-04	12	71	2	EFO_0021013
Disease	stomach cancer (is_marker_for)	CALR SRC ASPM NUF2	3.89e-04	142	71	4	DOID:10534 (is_marker_for)
Disease	Microcephaly	NSD2 CARS1 NCAPH	5.73e-04	67	71	3	C0025958
Disease	lung non-small cell carcinoma (is_marker_for)	CALR NSD2 NUF2 NCAPH	7.48e-04	169	71	4	DOID:3908 (is_marker_for)
Disease	X-12063 measurement	ASIC2 MATR3 SKA1 DNAH5	1.07e-03	186	71	4	EFO_0021283
Disease	lung adenocarcinoma (is_marker_for)	SRC NUF2 PLOD2	1.14e-03	85	71	3	DOID:3910 (is_marker_for)
Disease	intestinal permeability measurement	STAB2 ASIC2	1.79e-03	26	71	2	EFO_0011031
Disease	thrombocytopenia (is_implicated_in)	SRC MASTL	1.93e-03	27	71	2	DOID:1588 (is_implicated_in)
Disease	Huntington disease, disease progression measurement	KIF9 ST8SIA6	2.38e-03	30	71	2	EFO_0008336, MONDO_0007739

Protein segments in the cluster

Peptide	Gene	Start	Entry
HIVKVVAKKYRNFDI	CLIC4	196	Q9Y696
QLVYAHKKVNKSKVT	ANKRD30B	1316	Q9BXX2
RQKLKKVFQQHYTNK	BUB1	1051	O43683
VILHFKNKYHENKKL	CALR3	146	Q96L12
KVVDKFIKQRDYHQQ	COG4	316	Q9H9E3
KFQINYDKHIKVNKK	GVINP1	1941	Q7Z2Y8
KKIIQNKKTCVEYKH	MASTL	456	Q96GX5
ELIVKHKFTKAYKSV	AOPEP	751	Q8N6M6
KRCFAHYKQVKKLNK	DNAJC3	256	Q13217
HYKQVKKLNKLIESA	DNAJC3	261	Q13217
QHKEYLNLKKTAIKI	ASPM	2086	Q8IZT6
KYRANKKKQKVFQHN	ASPM	2586	Q8IZT6
ALRQKANFKHYKPKQ	ASIC2	136	Q16515
KAKLYHKQRHAEKIQ	NSA2	46	O95478
EKVHKYNLAVTDKLK	RASSF3	56	Q86WH2
VKVAIKDKQVKYFIH	MORF4L1	31	Q9UBU8
IDYIQFLHKEKKKQE	MLX	181	Q9UH92
HYQKLKKFLNKLAEE	MATR3	826	P43243
LLQSKEEKKYHSQKQ	KIAA0895	111	Q8NCT3
KNKHFKVQLKETVYC	NCK1	326	P16333
HLKYFSQKQDVVLIK	DST	6661	Q03001
LYKLFKAIKHQVEKG	PLXNB2	1421	O15031
QFKINKKHEDVKQYK	NUF2	356	Q9BZD4
KLKGQKKSARQYHVQ	NSD2	251	O96028
VTLFKNAIIKNAYKK	POMC	251	P01189
AHFNADYRKKQKAKV	GABRD	331	O14764
NAKVKIEQKHNYLKT	KIF9	766	Q9HAQ2
FLVKAKIYKHAGNIK	NAA15	411	Q9BXJ9
LKKFQKANHKVVFAA	PLOD2	126	O00469
YQHEKLFIQVKGKKS	PALB2	551	Q86YC2
NIYQQKIKDLHKKYS	OTUB1	66	Q96FW1
NLVAAYEKAKKKHQN	MCC	771	P23508
KPAKIDHKQYFRKQV	IGSF10	2036	Q6WRI0
KQLYVKHKVDLFYKL	DOCK3	101	Q8IZD9
IIKKVNGQKFVYKFV	ELK4	71	P28324
QKHKTFVEKYEKQIK	CDC37	146	Q16543
TKKVHVIFNYKGKNV	CALR	141	P27797
FSIHLKQKPKYVKFQ	CCDC168	926	Q8NDH2
KTYKRKSVKFQNHIS	ERCC6L2	1341	Q5T890
KAAIKAIKLYKHVVQ	SCAF4	31	O95104
KAAIKAIKFYKHVVQ	SCAF8	31	Q9UPN6
IKLKQEYQLCFHKTK	DNAH5	436	Q8TE73
NIVIQKKKYNKQHII	PLEKHF2	66	Q9H8W4
YVQKEKQKVVSAVKH	SFI1	266	A8K8P3
NAKGLNVKHYKIRKL	SRC	196	P12931
VKKKLQKKHSQHYQI	TRIM33	1006	Q9UPN9
LKKYSHVNKKALDQF	SMC3	976	Q9UQE7
SQDHFKKYLVKLKSI	SOS2	906	Q07890
NKNFYDKKTAIHKAL	CARS1	491	P49589
KEINKAVISKYKILH	SKA1	166	Q96BD8
YEKTHVCNLKKFKVF	MKLN1	76	Q9UL63
LKNDYNKETFTLKHK	MKLN1	106	Q9UL63
HSLYLKVKGNVFKNK	RPL19	121	P84098
KARQKVLFFHPKYLK	ST8SIA6	291	P61647
VFIKYTKLKKIFLQH	RXFP2	156	Q8WXD0
KHQIKQAVKKLYDID	RPL23A	106	P62750
AYKNVKFVLKHKVAQ	SSR3	76	Q9UNL2
VFTYAKNKFKNKRLL	ACSL3	91	O95573
KQEALKHFQKQVKYR	CCDC15	76	Q0P6D6
LKKQLYNIYAKHTKQ	CLPP	201	Q16740
QKVNKIEIHYAKTAK	NCAPH	626	Q15003
KAHIKLNTKKLYQAD	CLUAP1	76	Q96AJ1
KIFQCDKYVKVLHKF	ZNF273	176	Q14593
HFAEQIAKAKFIVKK	RTCA	326	O00442
KVQKLQEKIYFALQH	RORB	391	Q92753
SDYKKKKHVFKLQTQ	SPTBN4	2486	Q9H254
QDNKDKLKEYLKFHV	STAB2	1801	Q8WWQ8
EKVLSHKQAHVQYKK	ZNF630	241	Q2M218
VKVFHKYSNAKRHKI	ZNF708	146	P17019
KPFKAKYKLVNHIRV	ZIC1	281	Q15915
AIHLKKLNFLKSQKY	ZBTB49	306	Q6ZSB9
KKLAEEQQKQYKVHL	UBTF	616	P17480
SKIFQCDKYVKVFHK	ZNF680	151	Q8NEM1
KKVFTYKANLKEHQR	ZSCAN5C	446	A6NGD5
IQRFHKYDAFKKNLK	ZNF300	181	Q96RE9
KAKQVLKIIASYKHT	YTHDF2	536	Q9Y5A9
HQVEIKVYKQKVKHL	GAS8	91	O95995
KVYKQKVKHLLYEHQ	GAS8	96	O95995